Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Journal of Immigrant and Minority Health|January 31, 2012
Breast cancer subtypes in Asian-Americans differ according to Asian ethnic groupEllen Chuang, Christos Paul, Arielle Flam, et al.Clinical Breast Cancer|August 14, 2010
Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancerAlison K Conlin, Andrew D Seidman, Ariadne Bach, et al.Clinical Breast Cancer|July 9, 2013
Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancerAndrew D Seidman, Alison K Conlin, Ariadne Bach, et al.Cancer|January 28, 2003
A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinomaAmy D Tiersten, Caron Nelsen, Susan Talbot, et al.Human Genetics|April 20, 2024
A novel network-based method identifies a cuproplasia-related pan-cancer gene signature to predict patient outcomeVu Viet Hoang Pham, Toni Rose Jue, Jessica Lilian Bell, et al.Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
Tumor CTR1 and serum copper dynamics reveal a coordinated copper axis linked to high-grade triple-negative breast cancer biologyVinit C Shanbhag, Nikita Gudekar, Muhammad Yasir, et al.Clinical Breast Cancer|December 3, 2014
Disease-free survival according to the use of postmastectomy radiation therapy after neoadjuvant chemotherapyHimanshu Nagar, Dustin Boothe, Paula S Ginter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabineEdith A Perez, Guillermo Lerzo, Xavier Pivot, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapyClare Taylor, Dawn Hershman, Nina Shah, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapyHenri Roché, Louise Yelle, Francesco Cognetti, et al.Pageof 8